RxDoctor Payments DataLook up a doctor →

Judy Lim, MD

Family Medicine · Newark, DENPI 1083667208

Payments from drug & device makers

$11,712in general payments, 2019–2025

Across 516 payments — averaging $22.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • GSK$2K
  • AbbVie$1K
  • Lilly USA, LLC$1K
  • Novo Nordisk$832
  • Boehringer Ingelheim$748
  • plus $4K from 40 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca69$2,005
GSK59$1,556
AbbVie(2 entities)47$1,118
Lilly USA, LLC49$1,051
Novo Nordisk48$832
Boehringer Ingelheim31$748
Pfizer37$588
Abbott13$373
Sanofi-aventis U.S. LLC8$313
Amgen10$293
Johnson & Johnson14$290
Bayer14$258
Merck13$242
Astellas Pharma US Inc13$223
Otsuka America Pharmaceutical, Inc.11$191
Biohaven Pharmaceutical Holding Company Ltd.10$187
Eisai Inc.4$144
Novartis10$140
Esperion Therapeutics, Inc.1$120
Exact Sciences4$84
Xeris Pharmaceuticals, Inc.4$72
Endo Pharmaceuticals Inc.4$70
Idorsia Pharmaceuticals US Inc4$67
Biocryst US Sales Co., LLC3$67
Vanda Pharmaceuticals Inc.3$66
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$61
Tactile Systems Technology Inc2$59
Covis Pharma GmbH2$47
Sumitomo Pharma America, Inc.2$46
Indivior Inc.2$46
Alkermes, Inc.3$43
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC3$42
Gilead2$32
Lundbeck LLC1$26
Amarin Pharma, Inc.2$26
Avanos Medical1$22
Fidia Pharma USA Inc.1$19
Teva Pharmaceuticals USA, Inc.1$19
Alk-abello, Inc1$19
Arbor Pharmaceuticals, Inc.1$17
Kowa Pharmaceuticals America, Inc.1$17
Corium, LLC1$16
Seqirus USA Inc1$16
Biohaven Pharmaceuticals, Inc.1$14
Braeburn Inc.1$14
Supernus Pharmaceuticals, Inc.1$12

How this compares

$11,712 in reported general payments places this provider in the 90th percentile of 352 family medicine providers in Delaware.

See all family medicine providers in Delaware →

Medicare billing

Part B allowed, 2024
$109,300
Medicare patients
248
Services billed
1,287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Newark

See the full list for Delaware →

Where these figures come from

Is this you, or does something look wrong? →